Initial triggering of complement

Pathway network for the Initial triggering of complement SuperPath

Sources:
  • Reactome
  • WikiPathways
  • Sino Biological
  • QIAGEN

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Initial triggering of complement SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Immunodeficiency due to a classical component pathway complement deficiencyEnrichmentC1QA, C1QB, C1QC, C1R, C1S10.96
2Immunodeficiency due to a late component of complement deficiencyEnrichmentC5, C6, C7, C8A, C8B, C8G, C910.58
3C1q deficiency 1EnrichmentC1QA, C1QB, C1QC10.25
4Atypical hemolytic uremic syndrome with complement gene abnormalityEnrichmentC3, CD46, CFB, CFH10.09
53mc syndromeEnrichmentCOLEC10, COLEC11, MASP18.56
6Genetic atypical hemolytic-uremic syndromeEnrichmentC3, CD46, CFH8.50
7Systemic lupus erythematosus 16EnrichmentC1QA, C1R, C4A7.43
8Periodontal ehlers-danlos syndromeEnrichmentC1R, C1S6.79
9Ehlers-danlos syndrome, periodontal type, 1EnrichmentC1R, C1S6.31
10Ehlers-danlos syndrome, periodontal type, 2EnrichmentC1R, C1S6.31
11Complement component 6 deficiencyEnrichmentC6, C8B6.22
12Atypical hemolytic-uremic syndromeEnrichmentC3, CD46, CFH5.84
13Macular degeneration, age-related, 14EnrichmentC2, CFB5.64
14Hellp syndromeEnrichmentCD46, CFH4.86
153mc syndrome 1EnrichmentMASP13.43
16Ficolin 3 deficiencyEnrichmentFCN33.43
17Masp2 deficiencyEnrichmentMASP23.43
18Rheumatic heart diseaseEnrichmentFCN33.43
19Immunodeficiency due to ficolin3 deficiencyEnrichmentFCN33.43
20Immunodeficiency due to masp-2 deficiencyEnrichmentMASP23.43
21Hemolytic uremic syndrome, atypical 4EnrichmentCFB3.43
22Complement factor d deficiencyEnrichmentCFD3.43
23Hemolytic uremic syndrome, atypical 5EnrichmentC33.43
24Properdin deficiency, x-linkedEnrichmentCFP3.43
25Macular degeneration, age-related, 9EnrichmentC33.43
26Complement component 3 deficiency, autosomal recessiveEnrichmentC33.43
27Complement factor b deficiencyEnrichmentCFB3.43
28Complement component 3 deficiencyEnrichmentC33.43
29Membranoproliferative glomerulonephritisEnrichmentC33.43
30Primary membranoproliferative glomerulonephritisEnrichmentC33.43
31Recurrent neisseria infections due to factor d deficiencyEnrichmentCFD3.43
32C1q deficiency 3EnrichmentC1QC3.35
33C1q deficiency 2EnrichmentC1QB3.35
34Mannose-binding lectin deficiencyEnrichmentMBL23.23
35Cyclic neutropeniaEnrichmentCFD3.13
36Complement component 5 deficiencyEnrichmentC53.09
37Complement component 7 deficiencyEnrichmentC73.09
38Complement component 8 deficiency, type iEnrichmentC8A3.09
39Macular degeneration, age-related, 15EnrichmentC93.09
40Eculizumab, poor response toEnrichmentC53.09
41Complement component 9 deficiencyEnrichmentC93.09
42Complement component 8 deficiency, type iiEnrichmentC8B3.09
43Complement component c1s deficiencyEnrichmentC1S3.05
44Neutropenia, severe congenital, 1, autosomal dominantEnrichmentCFD2.96
453mc syndrome 2EnrichmentCOLEC112.93
46Complement component 2 deficiencyEnrichmentC22.81
47Basal laminar drusenEnrichmentCFH2.81
48Macular degeneration, age-related, 4EnrichmentCFH2.81
49Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathyEnrichmentCD552.81
50Blood group, cromer systemEnrichmentCD552.81
51Complement factor h deficiencyEnrichmentCFH2.81
52Hemolytic uremic syndrome, atypical 2EnrichmentCD462.81
53Hemolytic anemia, cd59-mediated, with or without immune-mediated polyneuropathyEnrichmentCD592.81
54Protein-losing enteropathyEnrichmentCD552.81
55Genetic hemolytic uremic syndromeEnrichmentCFH2.81
56Immunodeficiency with factor h anomalyEnrichmentCFH2.81
57LathosterolosisEnrichmentC52.79
58Complement component 4a deficiencyEnrichmentC4A2.79
59Blood group, chido/rodgers systemEnrichmentC4A2.79
60Complement component 4b deficiencyEnrichmentC4B2.79
613mc syndrome 3EnrichmentCOLEC102.75
62Systemic lupus erythematosusEnrichmentC4A, C4B2.75
63Amyotrophic lateral sclerosis 10 with or without frontotemporal dementiaEnrichmentMASP22.73
64Immunodeficiency, common variable, 2EnrichmentCR22.51
65Immunodeficiency, common variable, 7EnrichmentCR22.51
66Nephrotic syndrome, type 7EnrichmentCFH2.51
67De novo thrombotic microangiopathy after kidney transplantationEnrichmentCFH2.51
68Systemic lupus erythematosus 9EnrichmentCR22.33
69Familial drusenEnrichmentCFH2.33
70Thrombotic microangiopathyEnrichmentCD462.21
71Hemolytic uremic syndrome, atypical 1EnrichmentCFH2.11
72C3 glomerulopathyEnrichmentCFH2.11
73Ehlers-danlos syndromeEnrichmentC1R2.08
74Severe covid-19EnrichmentFCN21.97
75Cystic fibrosisEnrichmentMBL21.73
76Chronic kidney diseaseEnrichmentCFH1.70
77Behcet syndromeEnrichmentC4A1.52
78Hereditary retinal dystrophyEnrichmentCFH0.44
79Fundus dystrophyEnrichmentCFH0.44

Loading...
Loading...
Loading...